In recent years, polymorphisms and mutations in genes within the ATM-BRCA1-CHEK2 DNA repair pathway have been investigated in various types of cancer, including thyroid cancer [22,23,32]. This evidence concerns the gene CHEK2 and thyroid gland carcinoma.